ELENCO PUBBLICAZIONI DAL 1993 A FEBBRAIO 2009 - Data - CPO

243. CARNINO F, FUDA G, CICCONE G, ISKRA L, GUERCIO E, DADONE D, CONTE PF. Significance of lymph node sampling
in epithelial carcinoma of the ovary. Gynecol Oncol 1997; 65: 467-472.
244. CAROSSO A, BUGIANI M, MIGLIORE E, PICCIONI P, ANTÒ JM, DE MARCO R. Reference values of total serum IgE and
their significance in the diagnosis of allergy in the European young adult population. Int Arch Allergy
Immunol 2007; 142: 230-8.
245. CAROZZI F, CONFORTINI M, DALLA PALMA P, DEL MISTRO A, GILLIO-TOS A, DE MARCO L, GIORGI-ROSSI P, PONTENANI
G, ROSSO S, SANI C, SINTONI C, SEGNAN N, ZORZI M, CUZICK J, RIZZOLO R, RONCO G; NEW TECHNOLOGIES FOR
CERVIVAL CANCER SCREENING (NTCC) WORKING GROUP.Use of p16-INK4A overexpression to increase the
specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.
Lancet Oncol 2008; 9: 937-45. (IF 12.247)
246. CAROZZI F, NOFERINI D, CONFORTINI M, CIATTO S, MADDAU C, RONCO G. The value of HPV testing in predicting the
development of high grade lesions: a case control study. Atti de "27th European Congress of cytology"
Lillehammer 16-19 sett. 2000. Cytopathology 2000; 11: 363-467.
247. CAROZZI F, RONCO G, CONFORTINI M, NOFERINI D, MADDAU G, CIATTO S, SEGNAN N. Predcition of high grade
cervical intraepithelial neoplasia in cytologically normal women by human papillomavirus testing. Br J
Cancer 2000; 83: 1462-7.
248. CAROZZI FM, DEL MISTRO A, CONFORTINI M, SANI C, PULITI D, TREVISAN R, DE MARCO L, TOS AG, GIRLANDO S, PALMA
PD, PELLEGRINI A, SCHIBONI ML, CRUCITTI P, PIEROTTI P, VIGNATO A, RONCO G. Reproducibility of HPV DNA
Testing by Hybrid Capture 2 in a Screening Setting. Am J Clin Pathol 2005; 124: 716-21.
249. CERRUTI MAINARDI P, PASTORE G, ZWEIER C, RAUCH A. Mowat-Wilson syndrome and mutation in the zinc finger
homeo box 1B gene: a well defined clinical entity. J Med Genet 2004; 41: 16.
250. CHANG ET, MONTGOMERY SM, RICHIARDI L, EHLIN A, EKBOM A, LAMBE M. Number of siblings and risk of Hodgkin's
lymphoma. Cancer Epidemiol Biomarkers Prev 2004; 13: 1236-43.
251. CHELLINI E, TALASSI F, CICCONE G, BISANTI L, RUSCONI F, PIFFER S, BIGGERI A, PETRONIO MG, SESTINI P, FORASTIERE
F, DE SARIO M, PISTELLI R, CORBO G, VIEGI G; Gruppo Collaborativo SIDRIA-2. I cambiamenti delle
caratteristiche sociali e dei fattori di rischio per l’asma e le allergie tra i bambini e gli adolescenti italiani.
Epidemiol Prev 2005; 29: 80-5.
252. CHIÒ A, CICCONE G, CALVO A, VERCELLINO M, DI VITO N, GHIGLIONE P, MUTANI R. Validity of hospital morbidity
records for amyotrophic lateral sclerosis. A population-based study. J Clin Epidemiol 2002; 55: 723-7.
253. CHIO A, CUCATTO A, CALVO A, TERRENI AA, MAGNANI C, SCHIFFER D. Amyotrophic lateral sclerosis among the
migrant population to Piemonte, northwestern Italy. J Neurol 1999; 246: 175-80.
254. CHIÒ A, MAGNANI C, SCHIFFER D. Gompertzian analysis of amyotrophic lateral sclerosis mortality in Italy,
1957-1987; application to birth cohorts. Neuroepidemiol 1995; 14: 269-77.
255. CHIÒ A, MAGNANI C, SCHIFFER D. Prevalence of Parkinson’s disease in Northwestern Italy: Comparison of
tracer methodology and clinical ascertainment of cases. Movement Disorders 1998; 13: 400-5.
256. CHIÒ A, MAGNANI C, SCHIFFER D. The increase of Parkinson's disease mortality could be due to a cohort effect.
Acta Neurol Scand 1995; 92: 113-5.
257. CHIOCCHETTI A, COMI C, INDELICATO M, CASTELLI L, MESTURINI R, BENSI T, MAZZARINO MC, GIORDANO M, D'ALFONSO
S, MOMIGLIANO-RICHIARDI P, LIGUORI M, ZORZON M, AMOROSO A, TROJANO M, MONACO F, LEONE M, MAGNANI C,
DIANZANI U. Osteopontin gene haplotypes correlate with multiple sclerosis development and progression. J
Neuroimmunol 2005; 163: 172-8.
258. CIANCIO A, MANZINI P, CASTAGNO F, D'ANTICO S, REYNAUDO P, COUCOURDE L, CICCONE G, DEL PIANO M, BALLARE M,
PEYRE S, RIZZI R, BARLETTI C, BRUNO M, CARONNA S, CARUCCI P, VENON WDE B, DE ANGELIS C, MORGANDO A, MUSSO
A, REPICI A, RIZZETTO M, SARACCO G. Digestive endoscopy is not a major risk factor for transmitting hepatitis
C virus. Ann Intern Med 2005; 142: 903-9.
259. CIANCIO A, PICCIOTTO A, GIORDANINO C, SMEDILE A, TABONE M, MANCA A, MARENCO G, GARBAGNOLI P, ANDREONI M,
CARITI G, CALLERI G, SARTORI M, CUSUMANO S, GRASSO A, RIZZI R, GALLO M, BASSO M, ANSELMO M, PERCARIO G,
CICCONE G, RIZZETTO M, SARACCO G. A randomized trial of pegylated-interferon-alpha2a plus ribavirin with or
without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard
interferon and ribavirin. Aliment Pharmacol Ther 2006; 24: 1079-86.
17